Multidrug-resistant tuberculosis is associated with low plasma concentrations of human neutrophil peptides 1–3
OBJECTIVE: To investigate the relationship between HNP1-3 and MDR-TB.
DESIGN: We divided 42 patients with post-primary pulmonary TB into two groups according to their drug susceptibility test results: the drug-susceptible group (n = 21) and the MDR-TB group (n = 21). The concentration of HNP1-3 in the plasma of all specimens was measured by enzyme-linked immunosorbent assay before treatment and 6, 18 and 24 months after. Duration of Mycobacterium tuberculosis in sputum and peripheral blood neutrophil counts were measured at the same time.
RESULTS: Before treatment, the plasma HNP1-3 concentration in the MDR-TB group was lower than that of healthy controls and the drug-susceptible group. After treatment, plasma HNP1-3 concentrations were higher than pre-treatment levels in the MDR-TB group, but were still lower than in healthy controls or the drug-susceptible group. The concentration of HNP1-3 was negatively correlated with the duration of M. tuberculosis in sputum, while it was positively correlated with neutrophils.
CONCLUSION: MDR-TB is associated with low plasma concentrations of HNP1-3.
Keywords: Mycobacterium tuberculosis; human neutrophil peptides 1, 2 and 3 (HNP1-3); multidrug-resistant; neutrophil; pulmonary tuberculosis
Document Type: Regular Paper
Affiliations: 1: Department of Respiratory Medicine, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China 2: Department of Respiratory Medicine, Hunan Geriatric Hospital, Changsha, Hunan, People's Republic of China 3: Department of Thoracic Medicine, Changsha Central Hospital, Changsha, Hunan, People's Republic of China
Publication date: 01 March 2011
The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.
The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites
Receive new issue alert- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content